SCHEMBL6979304

SCHEMBL6979304

O=C1CCCCC1CC1CCCO1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.41
ALDH1A1 P00352 3/20 0.41
KMT2A Q03164 4/20 0.40
MEN1 O00255 2/20 0.40
POLB P06746 1/20 0.40
RECQL P46063 1/20 0.40
MAPT P10636 1/20 0.39
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
CA4 P22748 3/20 0.38
KDM4E B2RXH2 3/20 0.38
CA6 P23280 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
HPGD P15428 3/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
HTT P42858 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6976158 0.96 CA1 (0.38) TSHRALDH1A1KMT2AMEN1POLB
SCHEMBL3103357 0.82 CA1 (0.41) ALDH1A1KMT2ACA1CA2CA4
SCHEMBL10052945 0.81 CA1 (0.44) ALDH1A1KMT2ACA1CA2CA4
SCHEMBL5918112 0.80 CA1 (0.48) ALDH1A1KMT2ACA1CA2CA4
SCHEMBL6968032 0.74 ALDH1A1 (0.38) TSHRALDH1A1KMT2AMEN1POLB
SCHEMBL6969473 0.73 KDM4E (0.45) ALDH1A1KMT2ACA1CA2CA4
SCHEMBL28769181 0.73 SLC6A4 (0.37) CA1CA2CA4CA6NPC1
SCHEMBL6976839 0.73 ALDH1A1 (0.37) TSHRALDH1A1KMT2AMEN1POLB
SCHEMBL11365204 0.73 KMT2A (0.41) TSHRALDH1A1KMT2AMEN1POLB
SCHEMBL28283616 0.73 NPC1 (0.41) ALDH1A1KMT2ACA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0821674-B1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2003-08-06 EP disclosed
US-6043261-A TREATMENT OF INFLAMMATORY CONDITIONS AFFECTING THE JOINTS, FOR EXAMPLE ARTHRITIS, INFLAMMATORY BOWEL DISEASE, CARDIOVASCULAR ISCHEMIA, DIABETES, HYPERALGESIA, CEREBRAL ISCHEMIA, THROMBOTIC STROKE, GLOBAL ISCHEMIA, NERVOUS SYSTEM DISORDERS G. D. SEARLE & CO. (US) 2000-03-28 US disclosed
US-6011028-A Cyclic amidino agents useful as nitric oxide synthase inhibitors G.D. SEARLE & CO. (US) 2000-01-04 US disclosed
US-5883251-A ENZYME INHIBITORS G. D. SEARLE & CO. (US) 1999-03-16 US disclosed
EP-0821674-A1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1998-02-04 EP disclosed
WO-1996033175-A1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1996-10-24 WO disclosed